Fuseya Yasuhiro, Kawamura Miyuki, Matsuda Eri, Takada Kozue, Watanabe Kiwamu, Fujitake Junko, Nakaya Yoshifumi
Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Intern Med. 2017;56(4):441-444. doi: 10.2169/internalmedicine.56.7522. Epub 2017 Feb 15.
We herein report a case of capsular warning syndrome (CWS) that was successfully treated with recombinant tissue plasminogen activator (rt-PA). A 70-year-old woman had repeated stereotyped transient ischemic attacks (TIAs) of right hemiparesis and dysarthria. After hospitalization, argatroban, aspirin, and cilostazol were started but were ineffective. Thirteen hours after the first episode of TIAs, severe symptoms occurred. Magnetic resonance imaging showed acute infarctions in the internal capsule to corona radiata, so we used rt-PA. Since then, the TIAs have not occurred, and the symptoms have considerably improved. This case suggests that rt-PA might be effective and safe for use in treating CWS.
我们在此报告一例采用重组组织型纤溶酶原激活剂(rt-PA)成功治疗的包膜警告综合征(CWS)病例。一名70岁女性反复出现刻板性短暂性脑缺血发作(TIA),表现为右侧偏瘫和构音障碍。住院后,开始使用阿加曲班、阿司匹林和西洛他唑,但均无效。首次TIA发作13小时后,出现严重症状。磁共振成像显示内囊至放射冠急性梗死,因此我们使用了rt-PA。此后,TIA未再发生,症状有了显著改善。该病例表明,rt-PA可能对治疗CWS有效且安全。